Gatti, M.; Bonazzetti, C.; Pascale, R.; Giannella, M.; Viale, P.; Pea, F.
Real-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin–Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Enterobacterales Secondary Bloodstream Infections: Findings from a Prospective Pilot Study. Microorganisms 2024, 12, 151.
https://doi.org/10.3390/microorganisms12010151
AMA Style
Gatti M, Bonazzetti C, Pascale R, Giannella M, Viale P, Pea F.
Real-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin–Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Enterobacterales Secondary Bloodstream Infections: Findings from a Prospective Pilot Study. Microorganisms. 2024; 12(1):151.
https://doi.org/10.3390/microorganisms12010151
Chicago/Turabian Style
Gatti, Milo, Cecilia Bonazzetti, Renato Pascale, Maddalena Giannella, Pierluigi Viale, and Federico Pea.
2024. "Real-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin–Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Enterobacterales Secondary Bloodstream Infections: Findings from a Prospective Pilot Study" Microorganisms 12, no. 1: 151.
https://doi.org/10.3390/microorganisms12010151
APA Style
Gatti, M., Bonazzetti, C., Pascale, R., Giannella, M., Viale, P., & Pea, F.
(2024). Real-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin–Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Enterobacterales Secondary Bloodstream Infections: Findings from a Prospective Pilot Study. Microorganisms, 12(1), 151.
https://doi.org/10.3390/microorganisms12010151
